Open-to-Accrual Therapeutic Trials

Dr Ted Johnson in lab

Protocol ID

Official Title

PI Name

Contact Person

Disease Site


 Phase 1 Trial
of Indoximod
in Combination
with Temozolomide-based Therapy for Children with Progressive
Primary Brain
 T. Johnson Robin Dobbins
Kimberly Gray
 Brain Tumor  I
Neuroblastoma Maintenance
Therapy Trial
Using Difluoromethylornithine (DFMO);
 C. McDonough Kimberly Gray  Neuroblastoma  II

AHOD1331  NCT02166463

A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents Protocol C. McDonough Robin Dobbins
Kimberly Gray
Classical Hodgkin Lymphoma III

Contact Us

Georgia Cancer Center Pediatric Immunotherapy
Augusta University
Health Science Campus
Georgia Cancer Research Center

Robin Dobbins, RN
Senior Clinical Research Nurse
Office: 706-721-2154

Beth Fisher, RN, PNP
Immunotherapy Nurse-Practitioner
Office: 706-723-0000

Kimberly Gray
Research Manager
Office: 706-721-1870

Theodore S. Johnson, M.D., Ph.D.
Director, Clinical Pediatric Immunotherapy Service
Georgia Cancer Center
Office: 706-721-4962
Fax:     (706) 721-4804